Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Keefe, Bruyette & Woods Maintains PacWest Bancorp (PACW) Market Perform Recommendation
Fintel reports that on April 6, 2023, Keefe, Bruyette & Woods maintained coverage of PacWest Bancorp (NASDAQ:PACW) with a Market Perform recommendation. Analyst Price Forecast
Keefe, Bruyette & Woods Maintains National Bank Holdings (NBHC) Market Perform Recommendation
Fintel reports that on April 6, 2023, Keefe, Bruyette & Woods maintained coverage of National Bank Holdings (NYSE:NBHC) with a Market Perform recommendation. Analyst Price
Morgan Stanley Maintains American Express (AXP) Overweight Recommendation
Fintel reports that on April 5, 2023, Morgan Stanley maintained coverage of American Express (NYSE:AXP) with a Overweight recommendation. Analyst Price Forecast Suggests 18.44% Upside
Raymond James Maintains Ameresco (AMRC) Outperform Recommendation
Fintel reports that on April 5, 2023, Raymond James maintained coverage of Ameresco (NYSE:AMRC) with a Outperform recommendation. Analyst Price Forecast Suggests 50.66% Upside As
Goldman Sachs Maintains Jackson Financial Inc – (JXN) Neutral Recommendation
Fintel reports that on April 5, 2023, Goldman Sachs maintained coverage of Jackson Financial Inc – (NYSE:JXN) with a Neutral recommendation. Analyst Price Forecast Suggests
Wells Fargo Maintains Acuity Brands (AYI) Overweight Recommendation
Fintel reports that on April 5, 2023, Wells Fargo maintained coverage of Acuity Brands (NYSE:AYI) with a Overweight recommendation. Analyst Price Forecast Suggests 22.46% Upside
JP Morgan Maintains Relay Therapeutics (RLAY) Overweight Recommendation
On April 5, 2023, JP Morgan maintained coverage of Relay Therapeutics with a Overweight recommendation. Analyst Price Forecast Suggests 103.68% Upside As of March 30,
Morgan Stanley Maintains M & T Bank (MTB) Overweight Recommendation
On April 5, 2023, Morgan Stanley maintained coverage of M & T Bank with a Overweight recommendation. Analyst Price Forecast Suggests 51.79% Upside As of
HC Wainwright & Co. Maintains Allogene Therapeutics (ALLO) Buy Recommendation
On April 4, 2023, HC Wainwright & Co. maintained coverage of Allogene Therapeutics with a Buy recommendation. Analyst Price Forecast Suggests 294.83% Upside As of
JP Morgan Maintains Kodiak Sciences (KOD) Neutral Recommendation
On April 4, 2023, JP Morgan maintained coverage of Kodiak Sciences with a Neutral recommendation. Analyst Price Forecast Suggests 149.09% Upside As of March 30,